Trials / Conditions / High Risk of Recurrence
High Risk of Recurrence
3 registered clinical trials studyying High Risk of Recurrence — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma NCT05602415 | Ruijin Hospital | Phase 2 |
| Recruiting | Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma NCT06327269 | Chang Gung Memorial Hospital | EARLY_Phase 1 |
| Completed | Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients W NCT02260505 | Centre Leon Berard | Phase 3 |